Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Register now for the “Q4 Earnings Season Wrap-Up.”
Join stock market expert Marc Chaikin (the creator of Chaikin Money Flow) and Explosive Options’ Bob Lang for a special earnings season wrap-up.

You’ll find out the biggest takeaways from recent earnings results and what it means for the market—and YOUR money. 

Menu

Cryolife (CRY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,098,379
  • Shares Outstanding, K 36,968
  • Annual Sales, $ 262,840 K
  • Annual Income, $ -3,810 K
  • 36-Month Beta 0.47
  • Price/Sales 4.06
  • Price/Cash Flow 40.94
  • Price/Book 3.85

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.03
  • Number of Estimates 1
  • High Estimate 0.03
  • Low Estimate 0.03
  • Prior Year 0.02
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.99 +24.16%
on 02/14/19
30.86 -3.48%
on 02/13/19
+1.34 (+4.73%)
since 01/18/19
3-Month
23.99 +24.16%
on 02/14/19
30.86 -3.48%
on 02/13/19
+0.56 (+1.90%)
since 11/21/18
52-Week
18.50 +61.00%
on 02/23/18
36.05 -17.38%
on 09/25/18
+11.33 (+61.44%)
since 02/21/18

Most Recent Stories

More News
Cryolife (CRY) Earnings Miss, Revenues Top Estimates in Q4

Cryolife (CRY) revenues increase year over year across all geographies and major segments.

ABT : 75.05 (-0.65%)
ANGO : 22.35 (-4.65%)
CRY : 29.81 (+0.34%)
CNMD : 74.76 (+1.41%)
CryoLife (CRY) Q4 Earnings Lag Estimates

CryoLife (CRY) delivered earnings and revenue surprises of -58.33% and 1.04%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

CRY : 29.81 (+0.34%)
CryoLife (CRY) Reports Next Week: Wall Street Expects Earnings Growth

CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CRY : 29.81 (+0.34%)
CryoLife Announces Release Date and Teleconference Call Details for 2018 Fourth Quarter and Year-end Financial Results

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2018 fourth quarter and year-end financial results will be released on Wednesday,...

CRY : 29.81 (+0.34%)
Recent Analysis Shows Brown Forman, CryoLife, Aspen Group, Taylor Devices, Synergy Pharmaceuticals, and Ramco-Gershenson Properties Trust Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Brown Forman Corporation...

RPT : 12.78 (-4.27%)
BF.A : 48.72 (+0.06%)
ASPU : 4.69 (+0.95%)
CRY : 29.81 (+0.34%)
SGYP : 0.30 (+3.33%)
TAYD : 12.94 (+1.49%)
CryoLife (CRY) Tops Q3 Earnings and Revenue Estimates

CryoLife (CRY) delivered earnings and revenue surprises of 33.33% and 0.15%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

CRY : 29.81 (+0.34%)
CryoLife (CRY) Q3 Earnings Preview: What to Expect

CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CRY : 29.81 (+0.34%)
CryoLife Reports Preliminary Financial Results for Third Quarter 2018 in Anticipation of Discussions with Senior Lenders Regarding Repricing Senior Credit Facility

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, in anticipation of discussions with its senior lenders regarding repricing its senior secured credit...

CRY : 29.81 (+0.34%)
Surgical Glue: Global Market Opportunities to 2023 featuring B. Braun Medical, Baxter International, Cohera Medical, Sealantis, CryoLife, and many more - ResearchAndMarkets.com

The "Global Surgical Glue Market Size, Share - Segmented by Product Type (Natural and Synthetic and Semi Synthetic), Application, End User, and Geography - Growth, Trends, and Forecast...

CRY : 29.81 (+0.34%)
Stocks End Challenging Week with modest losses

Stocks End Challenging Week with modest losses

DAN : 19.96 (-0.05%)
NTAP : 65.39 (+0.18%)
TWLO : 113.41 (-2.48%)
BIDU : 171.31 (+0.08%)
BBY : 59.81 (-0.85%)
CRY : 29.81 (+0.34%)
PKG : 98.51 (-2.19%)
URBN : 29.97 (-0.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade CRY with:

Business Summary

CryoLife, Inc. is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries. It operates throughout the U.S. and internationally. CryoLife manufactures and distributes BioGlue Surgical...

See More

Key Turning Points

2nd Resistance Point 30.56
1st Resistance Point 30.14
Last Price 29.81
1st Support Level 28.93
2nd Support Level 28.14

See More

52-Week High 36.05
Last Price 29.81
Fibonacci 61.8% 29.35
Fibonacci 50% 27.27
Fibonacci 38.2% 25.20
52-Week Low 18.50

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar